Search Results
Results found for " Soo-Kyung Ki"
Posts (207)
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
tested at 1 µM and in concentration–response formats Why image-based confirmation (and transparent Ki Ki values were then calculated using the Cheng–Prusoff equation, with CELT-331 parameters fully reported Table reporting the % of displacement measured at 1 µ M and the corresponding Ki for those showing a This transparent context is essential: two Ki values derived from different tracer–Kd conditions are resulting potencies spanned the low-nanomolar to submicromolar range: Most potent ligands : AAN396 (Ki
- The Five Traps of Ignoring Kinetics
If you’ve ever trusted a Ki value without asking how it was measured, you’ve already stepped into the Kinetics will. This session gives you precisely that. Respect it, and you’ll see why drugs with identical Ki values diverge in vivo. But kinetics unmasks them. But that’s timing, not a different kind of corn. That’s not pharmacology. That’s kinetics.
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Exploring the Hidden Dynamics: How Kinetics Reveals What Equilibrium Conceals in GPCR Research. We’re zeroing in on kinetic tools that reveal what steady-state data can’t—so you can vet leads faster interactions in the active conformation of GLP‑1 receptor Terry's Corner – Advanced Applications of GPCR Kinetics But kinetics tells the truth. Get functional—not just presence—readouts: Quantify affinity and kinetics where it matters.
Other Pages (79)
- Weekly News October 23 | Dr. GPCR Ecosystem
drugs—defining “irreversible” in real systems, anticipating PK/PD decoupling, and using k_inact/K_I when Ki
- Flash News: Your Hub for GPCR Insights and Scientific Conference Programs
This is the kind of advance that matters for anyone building tools, assays, or therapeutics around receptor In the discovery phase, one overlooked kinetic parameter or a misjudged model can set your team back It’s not always about covalent chemistry — often, it’s about kinetics. Binding kinetics are a design variable, as critical as potency or clearance. drugs—defining “irreversible” in real systems, anticipating PK/PD decoupling, and using k_inact/K_I when Ki
- 🚀 New Workshop: Practical Quantification of Allosteric Modulation Join Dr. Terry Kenakin on May 1st, 2025, for an advanced live workshop on allosteric modulators in GPCR drug discovery. Learn how to: ✔️ Identify, measure, and quantify allosteric properties ✔️ Apply functional allosteric models to determine mechanisms of action ✔️ Confirm allostery through kinetic analysis 📅 Date: May 1st, 2025 ⏳ Registration deadline: April 18th 📍 Live on Google Meet 🔗 Register now: https://www.ecosystem.drgpcr.com/event-details-registration/practical-quantification-of-allosteric-modulation #GPCR #Allostery #DrugDiscovery #Pharmacology | Dr. GPCR Ecosystem
✔️ Apply functional allosteric models to determine mechanisms of action ✔️ Confirm allostery through kinetic ✔️ Apply functional allosteric models to determine mechanisms of action✔️ Confirm allostery through kinetic




